 | • レポートコード：MRC2-11QY12664 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は転移性脊椎腫瘍のグローバル市場について調査・分析したレポートです。種類別（臨床検査、画像検査、生検）市場規模、用途別（病院・クリニック、外来手術センター、学術機関、研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別転移性脊椎腫瘍の競争状況、市場シェア ・世界の転移性脊椎腫瘍市場：種類別市場規模 2015年-2020年（臨床検査、画像検査、生検） ・世界の転移性脊椎腫瘍市場：種類別市場規模予測 2021年-2026年（臨床検査、画像検査、生検） ・世界の転移性脊椎腫瘍市場：用途別市場規模 2015年-2020年（病院・クリニック、外来手術センター、学術機関、研究センター、その他） ・世界の転移性脊椎腫瘍市場：用途別市場規模予測 2021年-2026年（病院・クリニック、外来手術センター、学術機関、研究センター、その他） ・北米の転移性脊椎腫瘍市場分析：米国、カナダ ・ヨーロッパの転移性脊椎腫瘍市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの転移性脊椎腫瘍市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の転移性脊椎腫瘍市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの転移性脊椎腫瘍市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Amgen、Novartis、Abbott、Beckman Coulter、Debiopharm Group、AbbVie、Bayer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A spine tumor is an abnormal growth of tissue found in and/or around the spinal column and/or spinal cord. More than 95% of all metastatic spinal tumors are found outside the dura (extradural) and within the vertebral body, and in more than half of the cases they are found on multiple levels of the spine.
It is common for cancer cells to metastasize, or spread, to bones. Most commonly, cancer cells spread to the lung, the liver, and the bones, respectively, and most bone metastases occur in the spine. The most common way for cancer cells to reach the spine is via the blood stream, after which they enter the bone marrow and begin to multiply.
Market Analysis and Insights: Global Metastases Spinal Tumor Market
The global Metastases Spinal Tumor market size is projected to reach US$ 1233.2 million by 2026, from US$ 1209.5 million in 2020, at a CAGR of 1.8%% during 2021-2026.
Global Metastases Spinal Tumor Scope and Market Size
Metastases Spinal Tumor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Metastases Spinal Tumor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche
Amgen
Novartis
Abbott
Beckman Coulter
Debiopharm Group
AbbVie
Bayer
Market segment by Type, the product can be split into
Laboratory tests
Imaging Tests
Biopsy
Market segment by Application, split into
Hospital And Clinics
Ambulatory Surgery Centers
Academic Institutes
Research Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Metastases Spinal Tumor Revenue
1.4 Market by Type
1.4.1 Global Metastases Spinal Tumor Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Laboratory tests
1.4.3 Imaging Tests
1.4.4 Biopsy
1.5 Market by Application
1.5.1 Global Metastases Spinal Tumor Market Share by Application: 2020 VS 2026
1.5.2 Hospital And Clinics
1.5.3 Ambulatory Surgery Centers
1.5.4 Academic Institutes
1.5.5 Research Centers
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Metastases Spinal Tumor Market Perspective (2015-2026)
2.2 Global Metastases Spinal Tumor Growth Trends by Regions
2.2.1 Metastases Spinal Tumor Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Metastases Spinal Tumor Historic Market Share by Regions (2015-2020)
2.2.3 Metastases Spinal Tumor Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Metastases Spinal Tumor Market Growth Strategy
2.3.6 Primary Interviews with Key Metastases Spinal Tumor Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Metastases Spinal Tumor Players by Market Size
3.1.1 Global Top Metastases Spinal Tumor Players by Revenue (2015-2020)
3.1.2 Global Metastases Spinal Tumor Revenue Market Share by Players (2015-2020)
3.1.3 Global Metastases Spinal Tumor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Metastases Spinal Tumor Market Concentration Ratio
3.2.1 Global Metastases Spinal Tumor Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Metastases Spinal Tumor Revenue in 2019
3.3 Metastases Spinal Tumor Key Players Head office and Area Served
3.4 Key Players Metastases Spinal Tumor Product Solution and Service
3.5 Date of Enter into Metastases Spinal Tumor Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Metastases Spinal Tumor Historic Market Size by Type (2015-2020)
4.2 Global Metastases Spinal Tumor Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Metastases Spinal Tumor Market Size by Application (2015-2020)
5.2 Global Metastases Spinal Tumor Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Metastases Spinal Tumor Market Size (2015-2020)
6.2 Metastases Spinal Tumor Key Players in North America (2019-2020)
6.3 North America Metastases Spinal Tumor Market Size by Type (2015-2020)
6.4 North America Metastases Spinal Tumor Market Size by Application (2015-2020)
7 Europe
7.1 Europe Metastases Spinal Tumor Market Size (2015-2020)
7.2 Metastases Spinal Tumor Key Players in Europe (2019-2020)
7.3 Europe Metastases Spinal Tumor Market Size by Type (2015-2020)
7.4 Europe Metastases Spinal Tumor Market Size by Application (2015-2020)
8 China
8.1 China Metastases Spinal Tumor Market Size (2015-2020)
8.2 Metastases Spinal Tumor Key Players in China (2019-2020)
8.3 China Metastases Spinal Tumor Market Size by Type (2015-2020)
8.4 China Metastases Spinal Tumor Market Size by Application (2015-2020)
9 Japan
9.1 Japan Metastases Spinal Tumor Market Size (2015-2020)
9.2 Metastases Spinal Tumor Key Players in Japan (2019-2020)
9.3 Japan Metastases Spinal Tumor Market Size by Type (2015-2020)
9.4 Japan Metastases Spinal Tumor Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Metastases Spinal Tumor Market Size (2015-2020)
10.2 Metastases Spinal Tumor Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Metastases Spinal Tumor Market Size by Type (2015-2020)
10.4 Southeast Asia Metastases Spinal Tumor Market Size by Application (2015-2020)
11 India
11.1 India Metastases Spinal Tumor Market Size (2015-2020)
11.2 Metastases Spinal Tumor Key Players in India (2019-2020)
11.3 India Metastases Spinal Tumor Market Size by Type (2015-2020)
11.4 India Metastases Spinal Tumor Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Metastases Spinal Tumor Market Size (2015-2020)
12.2 Metastases Spinal Tumor Key Players in Central & South America (2019-2020)
12.3 Central & South America Metastases Spinal Tumor Market Size by Type (2015-2020)
12.4 Central & South America Metastases Spinal Tumor Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview
13.1.3 Roche Metastases Spinal Tumor Introduction
13.1.4 Roche Revenue in Metastases Spinal Tumor Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview
13.2.3 Amgen Metastases Spinal Tumor Introduction
13.2.4 Amgen Revenue in Metastases Spinal Tumor Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Metastases Spinal Tumor Introduction
13.3.4 Novartis Revenue in Metastases Spinal Tumor Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Abbott
13.4.1 Abbott Company Details
13.4.2 Abbott Business Overview
13.4.3 Abbott Metastases Spinal Tumor Introduction
13.4.4 Abbott Revenue in Metastases Spinal Tumor Business (2015-2020)
13.4.5 Abbott Recent Development
13.5 Beckman Coulter
13.5.1 Beckman Coulter Company Details
13.5.2 Beckman Coulter Business Overview
13.5.3 Beckman Coulter Metastases Spinal Tumor Introduction
13.5.4 Beckman Coulter Revenue in Metastases Spinal Tumor Business (2015-2020)
13.5.5 Beckman Coulter Recent Development
13.6 Debiopharm Group
13.6.1 Debiopharm Group Company Details
13.6.2 Debiopharm Group Business Overview
13.6.3 Debiopharm Group Metastases Spinal Tumor Introduction
13.6.4 Debiopharm Group Revenue in Metastases Spinal Tumor Business (2015-2020)
13.6.5 Debiopharm Group Recent Development
13.7 AbbVie
13.7.1 AbbVie Company Details
13.7.2 AbbVie Business Overview
13.7.3 AbbVie Metastases Spinal Tumor Introduction
13.7.4 AbbVie Revenue in Metastases Spinal Tumor Business (2015-2020)
13.7.5 AbbVie Recent Development
13.8 Bayer
13.8.1 Bayer Company Details
13.8.2 Bayer Business Overview
13.8.3 Bayer Metastases Spinal Tumor Introduction
13.8.4 Bayer Revenue in Metastases Spinal Tumor Business (2015-2020)
13.8.5 Bayer Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Metastases Spinal Tumor Key Market Segments
Table 2. Key Players Covered: Ranking by Metastases Spinal Tumor Revenue
Table 3. Ranking of Global Top Metastases Spinal Tumor Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Metastases Spinal Tumor Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Laboratory tests
Table 6. Key Players of Imaging Tests
Table 7. Key Players of Biopsy
Table 8. Global Metastases Spinal Tumor Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Metastases Spinal Tumor Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Metastases Spinal Tumor Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Metastases Spinal Tumor Market Share by Regions (2015-2020)
Table 12. Global Metastases Spinal Tumor Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Metastases Spinal Tumor Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Metastases Spinal Tumor Market Growth Strategy
Table 18. Main Points Interviewed from Key Metastases Spinal Tumor Players
Table 19. Global Metastases Spinal Tumor Revenue by Players (2015-2020) (Million US$)
Table 20. Global Metastases Spinal Tumor Market Share by Players (2015-2020)
Table 21. Global Top Metastases Spinal Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastases Spinal Tumor as of 2019)
Table 22. Global Metastases Spinal Tumor by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Metastases Spinal Tumor Product Solution and Service
Table 25. Date of Enter into Metastases Spinal Tumor Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Metastases Spinal Tumor Market Size by Type (2015-2020) (Million US$)
Table 28. Global Metastases Spinal Tumor Market Size Share by Type (2015-2020)
Table 29. Global Metastases Spinal Tumor Revenue Market Share by Type (2021-2026)
Table 30. Global Metastases Spinal Tumor Market Size Share by Application (2015-2020)
Table 31. Global Metastases Spinal Tumor Market Size by Application (2015-2020) (Million US$)
Table 32. Global Metastases Spinal Tumor Market Size Share by Application (2021-2026)
Table 33. North America Key Players Metastases Spinal Tumor Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Metastases Spinal Tumor Market Share (2019-2020)
Table 35. North America Metastases Spinal Tumor Market Size by Type (2015-2020) (Million US$)
Table 36. North America Metastases Spinal Tumor Market Share by Type (2015-2020)
Table 37. North America Metastases Spinal Tumor Market Size by Application (2015-2020) (Million US$)
Table 38. North America Metastases Spinal Tumor Market Share by Application (2015-2020)
Table 39. Europe Key Players Metastases Spinal Tumor Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Metastases Spinal Tumor Market Share (2019-2020)
Table 41. Europe Metastases Spinal Tumor Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Metastases Spinal Tumor Market Share by Type (2015-2020)
Table 43. Europe Metastases Spinal Tumor Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Metastases Spinal Tumor Market Share by Application (2015-2020)
Table 45. China Key Players Metastases Spinal Tumor Revenue (2019-2020) (Million US$)
Table 46. China Key Players Metastases Spinal Tumor Market Share (2019-2020)
Table 47. China Metastases Spinal Tumor Market Size by Type (2015-2020) (Million US$)
Table 48. China Metastases Spinal Tumor Market Share by Type (2015-2020)
Table 49. China Metastases Spinal Tumor Market Size by Application (2015-2020) (Million US$)
Table 50. China Metastases Spinal Tumor Market Share by Application (2015-2020)
Table 51. Japan Key Players Metastases Spinal Tumor Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Metastases Spinal Tumor Market Share (2019-2020)
Table 53. Japan Metastases Spinal Tumor Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Metastases Spinal Tumor Market Share by Type (2015-2020)
Table 55. Japan Metastases Spinal Tumor Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Metastases Spinal Tumor Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Metastases Spinal Tumor Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Metastases Spinal Tumor Market Share (2019-2020)
Table 59. Southeast Asia Metastases Spinal Tumor Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Metastases Spinal Tumor Market Share by Type (2015-2020)
Table 61. Southeast Asia Metastases Spinal Tumor Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Metastases Spinal Tumor Market Share by Application (2015-2020)
Table 63. India Key Players Metastases Spinal Tumor Revenue (2019-2020) (Million US$)
Table 64. India Key Players Metastases Spinal Tumor Market Share (2019-2020)
Table 65. India Metastases Spinal Tumor Market Size by Type (2015-2020) (Million US$)
Table 66. India Metastases Spinal Tumor Market Share by Type (2015-2020)
Table 67. India Metastases Spinal Tumor Market Size by Application (2015-2020) (Million US$)
Table 68. India Metastases Spinal Tumor Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Metastases Spinal Tumor Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Metastases Spinal Tumor Market Share (2019-2020)
Table 71. Central & South America Metastases Spinal Tumor Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Metastases Spinal Tumor Market Share by Type (2015-2020)
Table 73. Central & South America Metastases Spinal Tumor Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Metastases Spinal Tumor Market Share by Application (2015-2020)
Table 75. Roche Company Details
Table 76. Roche Business Overview
Table 77. Roche Product
Table 78. Roche Revenue in Metastases Spinal Tumor Business (2015-2020) (Million US$)
Table 79. Roche Recent Development
Table 80. Amgen Company Details
Table 81. Amgen Business Overview
Table 82. Amgen Product
Table 83. Amgen Revenue in Metastases Spinal Tumor Business (2015-2020) (Million US$)
Table 84. Amgen Recent Development
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Product
Table 88. Novartis Revenue in Metastases Spinal Tumor Business (2015-2020) (Million US$)
Table 89. Novartis Recent Development
Table 90. Abbott Company Details
Table 91. Abbott Business Overview
Table 92. Abbott Product
Table 93. Abbott Revenue in Metastases Spinal Tumor Business (2015-2020) (Million US$)
Table 94. Abbott Recent Development
Table 95. Beckman Coulter Company Details
Table 96. Beckman Coulter Business Overview
Table 97. Beckman Coulter Product
Table 98. Beckman Coulter Revenue in Metastases Spinal Tumor Business (2015-2020) (Million US$)
Table 99. Beckman Coulter Recent Development
Table 100. Debiopharm Group Company Details
Table 101. Debiopharm Group Business Overview
Table 102. Debiopharm Group Product
Table 103. Debiopharm Group Revenue in Metastases Spinal Tumor Business (2015-2020) (Million US$)
Table 104. Debiopharm Group Recent Development
Table 105. AbbVie Company Details
Table 106. AbbVie Business Overview
Table 107. AbbVie Product
Table 108. AbbVie Revenue in Metastases Spinal Tumor Business (2015-2020) (Million US$)
Table 109. AbbVie Recent Development
Table 110. Bayer Business Overview
Table 111. Bayer Product
Table 112. Bayer Company Details
Table 113. Bayer Revenue in Metastases Spinal Tumor Business (2015-2020) (Million US$)
Table 114. Bayer Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastases Spinal Tumor Market Share by Type: 2020 VS 2026
Figure 2. Laboratory tests Features
Figure 3. Imaging Tests Features
Figure 4. Biopsy Features
Figure 5. Global Metastases Spinal Tumor Market Share by Application: 2020 VS 2026
Figure 6. Hospital And Clinics Case Studies
Figure 7. Ambulatory Surgery Centers Case Studies
Figure 8. Academic Institutes Case Studies
Figure 9. Research Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Metastases Spinal Tumor Report Years Considered
Figure 12. Global Metastases Spinal Tumor Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Metastases Spinal Tumor Market Share by Regions: 2020 VS 2026
Figure 14. Global Metastases Spinal Tumor Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Metastases Spinal Tumor Market Share by Players in 2019
Figure 17. Global Top Metastases Spinal Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastases Spinal Tumor as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Metastases Spinal Tumor Revenue in 2019
Figure 19. North America Metastases Spinal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Metastases Spinal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Metastases Spinal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Metastases Spinal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Metastases Spinal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Metastases Spinal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Metastases Spinal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
急性脊髄損傷の世界市場（～2026年） Acute spinal cord injury (SCI) is a clinical condition caused due to a painful injury that result in a contusion or bruise to a fractional or complete spinal cord resulting into permanent disability and/or death in adults and children. The treatment of acute spinal cord injury is dependent on few f…- 脊椎手術の世界市場（～2026年） Back pain is a symptom of medical condition and the most common cause of back pain is a condition called intervertebral disc degeneration which means that the disc located between the vertebrae of the spine are breaking down with age. An increasing preference for Minimally Invasive Spinal Surgery, l…
- 内視鏡的脊椎手術の世界市場（～2026年） Endoscope spinal surgery is a non-invasive process in which complex spinal surgery is done by use of an endoscope. Endoscopic spinal surgery market shows promising growth due to rising Prevalence of chronic back pain and potential for endoscope spinal surgery to increase the effectiveness of existin…
- 脊椎画像の世界市場（～2026年） Market Analysis and Insights: Global Spinal Imaging Market The global Spinal Imaging market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…
- 脊髄刺激システムの世界市場（～2026年） The spinal cord stimulation system is also known as a neurostimulation system which provides the therapeutic treatment of the chronic back, neck and extremity pain. The increasing prevalence of chronic and neuropathic pain disorders and the increasing technological advancements to the spinal cord st…